Clinical Trial

A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

Study acronym: PIVOTAL
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the effectiveness and safety of Pitavastatin/Ezetimibe FDC in patients with hypercholesterolemia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-16.
Status change: Not Yet Recruiting → Recruiting 2025-08-03
Trial Details
NCT Number NCT07083206
Lead Sponsor Ahn-Gook Pharmaceuticals Co.,Ltd
Conditions Hypercholesterolemia, Dyslipidemias
Enrollment 4,500 participants
Start Date 2025-07-29
Primary Completion 2028-07 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-07